WS-635

N/A

Report date: 2023/06/29 14:51:39
NME

Base Information

Drug NameWS-635
Drug Alias NameWS-635SCY-635
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCyclophilin A inhibitorsCyclophilin D inhibitors
TargetsCyclophilin ACyclophilin D
Therapy Area/IndicationsEmergence DeliriumDeliriumHepatitis C, Chronic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesScynexis Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWaterstone Pharmaceutical (HK) LtdWaterstone Pharmaceuticals (Wuhan) Co Ltd
Inactive CompaniesScynexis Inc
Active IndicationsEmergence DeliriumDelirium
Inactive IndicationsHepatitis C, ChronicHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A